Clinical effects of combined treatment of traditional Chinese medicine and western medicine for viral hepatitis B cirrhosis and the effects on serum miR-122, miR-200a

References

• Ahmad, A., & Ahmad, R. (2014). Resveratrol mitigate structural changes and hepatic stellate cell activation in N′-nitrosodimethylamine-induced liver fibrosis via restraining oxidative damage. Chemico-Biological Interactions, 221, 1–12. https://doi.org/10.1016/j.cbi.2014.07.007
   PubMed Web of Science ®Google Scholar
• Arroyo, V., Moreau, R., Jalan, R., & Ginès, P. (2015). Acute-on-chronic liver failure: A new syndrome that will re-classify cirrhosis. Journal of Hepatology, 62(1), S131–143. https://doi.org/10.1016/j.jhep.2014.11.045
   PubMedGoogle Scholar
• Bandiera, S., Pfeffer, S., Baumert, T. F., & Zeisel, M. B. (2015). MiR-122–a key factor and therapeutic target in liver disease. Journal of Hepatology, 62(2), 448–457. https://doi.org/10.1016/j.jhep.2014.10.004
   PubMed Web of Science ®Google Scholar
• Blann, A. (2014). What is the purpose of liver function tests? Nursing Times, 110(6), 17–19.
   PubMedGoogle Scholar
• Burke, M. D. (2002). Liver function: Test selection and interpretation of results. Clinics in Laboratory Medicine, 22(2), 377–390. https://doi.org/10.1016/s0272-2712(01)00002-6
   PubMedGoogle Scholar
• Buster, E. H., van Erpecum, K. J., Schalm, S. W., Zaaijer, H. L., Brouwer, J. T., Gelderblom, H. C., de Knegt, R. J., Minke Bakker, C., Reesink, H. W., & Janssen, H. L. (2008). Treatment of chronic hepatitis B virus infection - Dutch national guidelines. The Netherlands Journal of Medicine, 66(7), 292–306.
   PubMedGoogle Scholar
• Chen, Y., & Xiao, Z. (2013). Therapeutic effect of resveratrol as well as resveratrol combined with praziquantel on the liver fibrosis due to Schistosoma japonicum infection in mice. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi = Chinese Journal of Parasitology & Parasitic Diseases, 31(5), 337–341.
   PubMedGoogle Scholar
• Hsu, A., Lai, C. L., & Yuen, M. F. (2011). Update on the risk of hepatocellular carcinoma in chronic hepatitis B virus infection. Current Hepatitis Reports, 10(2), 106–111. https://doi.org/10.1007/s11901-011-0094-2
   PubMedGoogle Scholar
• Hu, X., Liu, H., Wang, Z., Hu, Z., & Li, L. (2019). MiR-200a attenuated doxorubicin-induced cardiotoxicity through upregulation of Nrf2 in Mice. Oxidative Medicine and Cellular Longevity, 2019, 1512326. https://doi.org/10.1155/2019/1512326
   PubMedGoogle Scholar
• Jia, C., Zhang, Y., Xie, Y., Ren, Y., Zhang, H., Zhou, Y., Gao, N., Ding, S., & Han, S. (2019). MiR-200a-3p plays tumor suppressor roles in gastric cancer cells by targeting KLF12. Artificial Cells, Nanomedicine and Biotechnology, 47(1), 3697–3703. https://doi.org/10.1080/21691401.2019.1594857
   PubMed Web of Science ®Google Scholar
• Jiang, M., Lu, C., Zhang, C., Yang, J., Tan, Y., Lu, A., & Chan, K. (2012). Syndrome differentiation in modern research of traditional Chinese medicine. Journal of Ethnopharmacology, 140(3), 634–642. https://doi.org/10.1016/j.jep.2012.01.033
   PubMed Web of Science ®Google Scholar
• Kim, H. J., Cho, J. Y., Kim, Y. J., Gwak, G. Y., Paik, Y. H., Choi, M. S., Koh, K. C., Paik, S. W., Yoo, B. C., & Lee, J. H. (2015). Long-term efficacy of tenofovir disoproxil fumarate therapy after multiple nucleos(t)ide analogue failure in chronic hepatitis B patients. The Korean Journal of Internal Medicine, 30(1), 32–41. https://doi.org/10.3904/kjim.2015.30.1.32
   PubMedGoogle Scholar
• Lai, C. L., Wong, D. K., Wong, G. T., Seto, W. K., Fung, J., & Yuen, M. F. (2020). Rebound of HBV DNA after cessation of nucleos/tide analogues in chronic hepatitis B patients with undetectable covalently closed. JHEP Reports, 2(3), 100112. https://doi.org/10.1016/j.jhepr.2020.100112
   PubMedGoogle Scholar
• Liu, Y., Wang, M., Luo, Y., Chen, J., Lu, Y., Shi, Y., Tang, C., Zhou, Q., Zhang, H., Hu, Y., Su, S., & Chen, Q. (2017). MiRNA-target network analysis identifies potential biomarkers for traditional Chinese medicine (TCM) syndrome development evaluation in hepatitis B caused liver cirrhosis. Scientific Reports, 7(1), 11054. https://doi.org/10.1038/s41598-017-11351-5
   PubMedGoogle Scholar
• Long, J. K., Dai, W., Zheng, Y. W., & Zhao, S. P. (2019). MiR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease. Molecular Medicine, 25(1), 26. https://doi.org/10.1186/s10020-019-0085-2
   PubMedGoogle Scholar
• Lou, G., Song, X., Yang, F., Wu, S., Wang, J., Chen, Z., & Liu, Y. (2015). Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma. Journal of Hematology & Oncology, 8(1), 122. https://doi.org/10.1186/s13045-015-0220-7
   PubMedGoogle Scholar
• Lou, G., Yang, Y., Liu, F., Ye, B., Chen, Z., Zheng, M., & Liu, Y. (2017). MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis. Journal of Cellular and Molecular Medicine, 21(11), 2963–2973. https://doi.org/10.1111/jcmm.13208
   PubMed Web of Science ®Google Scholar
• Nan, Y. M., & Kong, L. L. (2018). Advances in diagnosis and treatment of liver cirrhosis with integrated traditional Chinese and Western medicine. Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology, 26(5), 328–331. https://doi.org/10.3760/cma.j.issn.1007-3418.2018.05.003
   PubMedGoogle Scholar
• O’Leary, J. G., Greenberg, C. S., Patton, H. M., & Caldwell, S. H. (2019). AGA clinical practice update: Coagulation in Cirrhosis. Gastroenterology, 157(1), 34–43.e31. https://doi.org/10.1053/j.gastro.2019.03.070
   PubMed Web of Science ®Google Scholar
• Ott, J. J., Stevens, G. A., Groeger, J., & Wiersma, S. T. (2012). Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine, 30(12), 2212–2219. https://doi.org/10.1016/j.vaccine.2011.12.116
   PubMed Web of Science ®Google Scholar
• Qu, J., Yu, Z., Li, Q., Chen, Y., Xiang, D., Tan, L., Lei, C., Bai, W., Li, H., Shang, Q., Chen, L., Hu, X., Lu, W., Li, Z., Chen, D., Wang, X., Zhang, C., Xiao, G., Qi, X. … Yang, Y. (2014). Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): Study protocol for a randomized controlled trial. Trials, 15, 438. https://doi.org/10.1186/1745-6215-15-438
   PubMedGoogle Scholar
• Schweitzer, A., Horn, J., Mikolajczyk, R. T., Krause, G., & Ott, J. J. (2015). Estimations of worldwide prevalence of chronic hepatitis B virus infection: A systematic review of data published between 1965 and 2013. The Lancet, 386(10003), 1546–1555. https://doi.org/10.1016/s0140-6736(15)61412-x
   PubMed Web of Science ®Google Scholar
• Shan, S., You, H., Niu, J., Shang, J., 4ie, W., Zhang, Y., Li, X., Ren, H., Tang, H., Ding, H., Wang, X., Nan, Y., Dou, X., Han, T., Zhang, L., Liu, X., Deng, C., Cheng, J., Wang, X. … Jia, J. (2019). Baseline characteristics and treatment patterns of the patients recruited to the china registry of hepatitis B. Journal of Clinical and Translational Hepatology, 7(X), 322–328. https://doi.org/10.14218/jcth.2019.00052
   PubMedGoogle Scholar
• Su, S., Wong, W. C., Zou, Z., Cheng, D. D., Ong, J. J., Chan, P., Ji, F., Yuen, M. F., Zhuang, G., Seto, W. K., & Zhang, L. (2022). Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: An economic evaluation. The Lancet Global Health, 10(2), e278–287. https://doi.org/10.1016/s2214-109x(21)00517-9
   PubMedGoogle Scholar
• Tan, Y. J. (2011). Hepatitis B virus infection and the risk of hepatocellular carcinoma. World Journal of Gastroenterology, 17(44), 4853–4857. https://doi.org/10.3748/wjg.v17.i44.4853
   PubMed Web of Science ®Google Scholar
• Wang, S. L., Yao, N. L., & Lv, W. L. (2007). Advances in studies on effect superiorities of traditional Chinese medicine on chronic hepatitis B. Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica, 32(23), 2468–2470.
   PubMedGoogle Scholar
• Wang, Y., Jiang, Y., Sun, X., Shen, X., Wang, H., Dong, C., Lu, B., Yan, Y., Lu, Y., Fasae, M. B., Liu, B., & Bai, Y. (2020). Downregulation of miR-200a protects cardiomyocyte against apoptosis. Biomedicine and Pharmacotherapy, 123, 109303. https://doi.org/10.1016/j.biopha.2019.109303
   PubMedGoogle Scholar
• Wilt, T. J., Shamliyan, T., Shaukat, A., Taylor, B. C., MacDonald, R., Yuan, J. M., Johnson, J. R., Tacklind, J., Rutks, I., & Kane, R. L. (2008). Management of chronic hepatitis B. Evidence Report/Technology Assessment, 1–671.
   Google Scholar
• Win, N. N., Kanda, T., Ogawa, M., Nakamoto, S., Haga, Y., Sasaki, R., Nakamura, M., Wu, S., Matsumoto, N., Matsuoka, S., Kato, N., Shirasawa, H., Yokosuka, O., Okamoto, H., & Moriyama, M. (2019). Superinfection of hepatitis a virus in hepatocytes infected with hepatitis B virus. International Journal of Medical Sciences, 16(10), 1366–1370. https://doi.org/10.7150/ijms.32795
   PubMedGoogle Scholar
• Wong, G. L., Chan, H. L., Wong, C. K., Leung, C., Chan, C. Y., Ho, P. P., Chung, V. C., Chan, Z. C., Tse, Y. K., Chim, A. M., Lau, T. K., & Wong, V. W. (2014). Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B. Journal of Hepatology, 60(2), 339–345. https://doi.org/10.1016/j.jhep.2013.09.029
   PubMed Web of Science ®Google Scholar
• Yang, N. H., Yuan, G. S., Zhou, Y. C., Liu, J. W., Huang, H. P., Hu, C. G., Xiong, L., Li, Y., Zhou, F. Y., Yang, S. L., & Zhou, Y. P. (2016). Entecavir combined with Fufang Biejia Ruangan tablet in treatment of chronic hepatitis B patients with liver fibrosis: 96-week efficacy analyses. Nan Fang Yi Ke da Xue Xue Bao = Journal of Southern Medical University, 36(6), 775–779.
   PubMedGoogle Scholar
• Zhao, X. J., Yu, H. W., Yang, Y. Z., Wu, W. Y., Chen, T. Y., Jia, K. K., Kang, L. L., Jiao, R. Q., & Kong, L. D. (2018). Polydatin prevents fructose-induced liver inflammation and lipid deposition through increasing miR-200a to regulate Keap1/Nrf2 pathway. Redox Biology, 18, 124–137. https://doi.org/10.1016/j.redox.2018.07.002
   PubMed Web of Science ®Google Scholar